Competitive intelligence on
small-molecule drugs and
the 80,000 global patents
covering them

Start your free trial now

No commitment — No credit card required

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: DIGOXIN

« Back to Dashboard

Summary for Tradename: DIGOXIN

Suppliers: see list3

Pharmacology for Tradename: DIGOXIN

Ingredient-typeCardiac Glycosides
Drug ClassCardiac Glycoside

Clinical Trials for: DIGOXIN

Digoxin Dosing in Heart Failure: A Simplified Nomogram Versus Standard Care
Status: Completed Condition: Heart Failure

Drug Interaction Study of Isavuconazole and Digoxin
Status: Completed Condition: Pharmacokinetics of Isavuconazole; Pharmacokinetics of Digoxin; Healthy Volunteers

Study to Evaluate the Effect of Solifenacin and Mirabegron on the Digoxin Concentrations in Blood in Healthy Subjects
Status: Completed Condition: Healthy Subjects; Pharmacokinetics; Drug-Drug Interaction (DDI)

A Phase 1 Study Evaluating Eliglustat's Effects on Pharmacokinetics, Safety & Tolerability of Digoxin in Healthy Adults
Status: Completed Condition: Healthy Volunteer

Drug Interaction Study of Digoxin and BI 10773
Status: Completed Condition: Healthy

to Evaluate Effect of Multi Doses Flibans 100 mg Film-c Tablets on Single Dose PK of Digoxin 0.5 mg, Healthy Volunteers
Status: Completed Condition: Healthy

Effect Of Maraviroc On The Pharmacokinetics Of Digoxin
Status: Completed Condition: Healthy; HIV Infections

A Study to Investigate the Effect of Steady-State TMC278 on the Pharmacokinetics of a Single Dose of Digoxin
Status: Completed Condition: Healthy

A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics and Safety of Digoxin in Healthy Volunteers.
Status: Completed Condition: Healthy

Investigate the Effect of AZD1656 on the Pharmacokinetics of Digoxin in Type 2 Diabetes Mellitus Patients
Status: Completed Condition: Type 2 Diabetes Mellitus

Courtesy of
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
ELIXIR;ORAL021648Aug 26, 2004RXYes<disabled><disabled>
Impax Labs
TABLET;ORAL078556Jul 20, 2009RXNo<disabled><disabled>
INJECTABLE;INJECTION040092Apr 25, 1996DISCNNo<disabled><disabled>
Wyeth Ayerst
INJECTABLE;INJECTION084386Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
Sun Pharm Inds Inc
TABLET;ORAL076363Jan 31, 2003DISCNNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access , or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology